COMMUNIQUÉS West-GlobeNewswire

Oxford Immunotec to Present at the 36th Annual J.P. Morgan Healthcare Conference
03/01/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, [...]
$600,000 California Purchase Order Fulfilled by Wildflower
03/01/2018
VANCOUVER, British Columbia, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (the “Company”) announced today the fulfillment of its initial purchase order announced December 14, 2017, through its [...]
Canada House Wellness Group Announces its 2018 Executive Team
03/01/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]
2nd Annual Medical Capital Innovation Competition to Take Place April 23-24, 2018
03/01/2018
CLEVELAND, Jan. 03, 2018 (GLOBE NEWSWIRE) -- BioEnterprise, in partnership with the Global Center for Health Innovation (Global Center), Cuyahoga County, and Healthcare Information and Management Systems Society (HIMSS [...]
MRI Interventions ClearPoint® Neuro Navigation System Utilized for the First Time in Minnesota
03/01/2018
IRVINE, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on Magnetic Resonance Imaging (MRI)-Guided Neurosurgical procedures, announced [...]
Sensoria Health and Optima Join Forces to Create Smart Diabetic Footwear: Motus Smart, Powered by Sensoria
03/01/2018
LAS VEGAS, Jan. 03, 2018 (GLOBE NEWSWIRE) -- At CES 2018, Sensoria® Health and Optima Molliter will announce a partnership to create the first smart diabetic footwear product that will monitor a patient's compliance to [...]
CURE Pharmaceutical to Present at 2018 Biotech Showcase
03/01/2018
OXNARD, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, will be a presenting company at the 2018 Biotech Showcase in San [...]
ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for Varlitinib From Array BioPharma
03/01/2018
SINGAPORE, Jan. 03, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN, 6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the [...]
Dr. Tomas Navratil nommé Head of Development de Nicox
03/01/2018
Communiqué de presse Dr. Tomas Navratil nommé Head of Development de Nicox ....................................... 3 janvier 2018 - diffusion à 7:30 Sophia Antipolis, France Nicox S.A. (Euronext Paris : FR0013018124, [...]
Nicox Appoints Tomas Navratil, Ph.D., as Head of Development
03/01/2018
Press Release Nicox Appoints Tomas Navratil, Ph.D., as Head of Development ................................................ January 3, 2018 - release at 7:30 am Sophia Antipolis, France Nicox SA (Euronext Paris: [...]
Basilea reports start of clinical phase 1 study in collaboration with the U.S. Adult Brain Tumor Consortium to explore BAL101553 in newly diagnosed glioblastoma
03/01/2018
Basel, Switzerland, January 03, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today the initiation of a phase 1 study conducted under its clinical study agreement with the Adult Brain Tumor Consortium (ABTC) [...]
Novartis Kisqali® received FDA Breakthrough Therapy designation for initial endocrine-based treatment in premenopausal women with HR+/HER2- advanced breast cancer
03/01/2018
Designation based on Phase III MONALEESA-7 results demonstrating superior efficacy of Kisqali in combination with oral endocrine therapy compared to oral endocrine therapy in pre- or perimenopausal women who received no [...]
Addex and Indivior Sign Strategic Partnership to Accelerate Development of GABAB PAMs as Addiction Treatments
03/01/2018
Addex Receives $5 Million Upfront, Potential Milestones of $330 Million and Tiered Royalties up to Double Digit Addex Receives $4 Million Research Funding over 2 years and Retains Rights to Advance Additional GABAB PAMs [...]
assessURhealth, LLC joins Greenway Health online Marketplace for comprehensive health IT solutions
03/01/2018
Tampa, FL, Jan. 02, 2018 (GLOBE NEWSWIRE) -- assessURhealth, LLC , a leading provider of mental and behavioral health screening software, today announced it has joined the Greenway Health online Marketplace of value- [...]
Tetraphase Pharmaceuticals Appoints Larry Tsai, M.D. to Chief Medical Officer
02/01/2018
WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant [...]
Tetraphase Pharmaceuticals Announces Submission of New Drug Application to FDA for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections (cIAI)
02/01/2018
WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant [...]
Supernus to Present at the 2018 J.P. Morgan Healthcare Conference
02/01/2018
ROCKVILLE, Md., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central [...]
Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Lead-In to Phase 3, Global Registrational Trial of FPA144 in Front-Line Advanced Gastric Cancer
02/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc . (Nasdaq: FPRX ), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today [...]
Envigo to Present at the 36th Annual JPMorgan Conference
02/01/2018
EAST MILLSTONE, N.J., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Envigo , a leading provider of nonclinical contract research services and research models, today announced that Adrian Hardy, Chief Executive Officer, and Patricia [...]

Pages